| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 16.42 | -0.07 (-0.42%) | 14.53 - 23.54 | 214.7 thousand (Below Avg) |
Market data as of 4:00PM 05/17/13. Quotes are delayed by at least 15 min.
| Open | 16.60 |
|---|---|
| Previous Close | 16.49 |
| Day's Range | 16.38 - 16.64 |
| Market Cap | 685.1M |
| Avg Volume (10 Day) | 372.6K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.7 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Tornier Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Over-Allotment Option
Business Wire - Wednesday 05/15/2013 4:00 PM ET
Tornier Announces Pricing of Public Offering of Ordinary Shares
Business Wire - Thursday 05/09/2013 9:21 PM ET
Tornier Announces Follow-on Offering of Ordinary Shares
Business Wire - Tuesday 05/07/2013 4:02 PM ET
Tornier Reports First Quarter 2013 Results
Business Wire - Tuesday 05/07/2013 4:01 PM ET
Tornier to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Business Wire - Friday 04/26/2013 4:00 PM ET
| TRNX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 7.34% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.28 | |
| LT Debt/Equity | 0.27 | |
| Earnings Yield | -- | |
| Price/Sales | 2.44 |
| Company | Last | Change |
|---|---|---|
| Luminex Corp | 18.41 | +1.66% |
| Antares Pharma Inc | 4.06 | +2.01% |
| Endologix Inc | 14.51 | +3.50% |
| Cantel Medical Corp | 34.76 | +0.35% |
| Merit Medical Systems Inc | 10.18 | +2.62% |
Data is delayed by at least 15 min.